Related Experiment Video
Updated: Feb 11, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex
Emma A van der Poest Clement1, Mustafa Sahin2, Jurriaan M Peters1
11 Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital and Harvard Medical, School, Boston, MA, USA.
Insights
Vigabatrin effectively treats various seizures in children with tuberous sclerosis complex (TSC) beyond infantile spasms. This study shows significant seizure reduction and freedom in most patients, with manageable side effects.
Area of Science:
- Neurology
- Pediatric Epilepsy
- Tuberous Sclerosis Complex Research
Background:
- Vigabatrin is a primary treatment for infantile spasms in tuberous sclerosis complex (TSC).
- Limited data exists on vigabatrin's efficacy for other seizure types in older children with TSC.
- Understanding alternative indications is crucial for comprehensive TSC management.
Purpose of the Study:
- To evaluate vigabatrin's effectiveness and safety in children over one year old with TSC experiencing various seizure types.
- To assess seizure reduction, seizure freedom, and treatment tolerability.
- To explore the potential of vigabatrin beyond its established role in infantile spasms.
Main Methods:
- Retrospective review of 201 children diagnosed with TSC.
- Analysis of data from 21 children over one year old who received vigabatrin for seizure management.
- Inclusion of seizure types, age at treatment onset, seizure outcomes, and adverse events.
Main Results:
- Vigabatrin was prescribed for epileptic spasms, tonic seizures, and status epilepticus.
- A significant majority of patients (20/21) experienced seizure reduction.
- Ten patients achieved complete seizure freedom, and four showed over 90% improvement.
- Successful tapering of vigabatrin was achieved in 9 patients.
- Reported side effects included rash and behavioral decline; no retinal toxicity was observed in monitored patients.
Conclusions:
- Vigabatrin demonstrates efficacy in treating epileptic spasms and tonic seizures in children with TSC beyond infancy.
- The drug appears well-tolerated in this age group, with a low incidence of significant side effects.
- Further research may support expanded use of vigabatrin for specific seizure types in older children with TSC.
Abstract:
Vigabatrin is recommended as first-line treatment for infantile spasms in tuberous sclerosis complex (TSC), but other indications in children with tuberous sclerosis complex are less known. We retrospectively reviewed 201 children with tuberous sclerosis complex, and identified 21 children older than 1 year started on vigabatrin for any indication and with sufficient follow-up data. The indication for vigabatrin was epileptic spasms (n = 13), tonic seizures (n = 5), both (n = 2), and status epilepticus (n = 1). Mean age of treatment onset was 4.0 years (range 1.1-18.3). All but 1 patient had a reduction in seizures. Ten patients became seizure free and 4 had an improvement of >90%. In 9 patients, vigabatrin was tapered successfully after 8 to 33 months. Side effects reported included rash (n = 1) and behavioral decline (n = 1). No retinal toxicity was detected in 14 of 21 patients with adequate ophthalmologic surveillance data. In conclusion, vigabatrin may be an effective treatment for epileptic spasms and tonic seizures beyond the infantile age.
Related Concept Videos
Tonicity in Animals
Tonicity in Animals
Vascular Spasm
Tonicity in Plants
Tonicity in Plants
Tonicity
Tonicity describes the capacity of a cell to lose or gain water depending on the solute...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

